Dr Reddy’s launches cancer drug biosimilar in India, targets 12 indications

Dr Reddy’s launches NIVORZ, a biosimilar to nivolumab, for 12 cancer indications after a 288-patient clinical programme, expanding its immuno-oncology portfolio.

Leave a Reply

Your email address will not be published. Required fields are marked *